Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy

Heart

Volumn 81, Issue 3, 1999, Pages 278-284

  Mundhenke, M ^a   Schwartzkopff, B ^a   Kostering M ^a   Deska, U ^a   Klein, R M ^a   Strauer, B E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Coronary circulation; Dilated cardiomyopathy; Endothelin; Myocardial oxygen consumption

Indexed keywords

CONTRAST MEDIUM; ENDOTHELIN 1; IOPROMIDE;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; FEMALE; HEART DILATATION; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0033048383     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.3.278     Document Type: Article

References (35)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cell. Nature 1988;332:411-15.
2. Lerman A, Hildebrand FL, Margulies KB, et al. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin Proc 1990;65:1441-5.
3. Love MP, McMurray JJV. Endothelin in chronic heart failure: current position and future prospects. Cardiovasc Res 1996;31:665-74.
4. Hiroe M, Hirata Y, Fujita N, et al. Plasma endothelin levels in idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:1114-15.
5. McMurray J, Ray S, Abdullah I, et al. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-9.
6. Pernow J, Wang QD. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 1997;33:518-26.
7. Pacher R, Stanek B, Hülsmann M, et al. Prognostic impact of big-endothelin plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996;27:633-41.
8. Pousset F, Isnard R, Lechat P, et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997;18:254-8.
9. Kiowski W, Sütsch G, Hunziker P, et al. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet 1995;346:732-6.
10. Sakai S, Miyauchi T, Sakurai T, et al. Endogenous endothelin-1 participates in the maintainance of cardiac function in rats with congestive heart failure. Circulation 1996;93:1214-22.
11. Thomas PB, Liu CK, Webb ML, et al. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol 1996;271:H2629-37.
12. Spinale FG, Walker JD, Mukherjee R, et al. Concomitant endothelin receptor subtype-A blockade during the progression of pacing induced congestive heart failure in rabbits: beneficial effects on left ventricular and myocyte function. Circulation 1997;95:1918-29.
13. Lerman A, Hildebrand FL, Aarhus LL, et al. Endothelin has biological actions at pathophysiological concentrations. Circulation 1991;83:1808-14.
14. Franco-Cereceda A. Endothelin and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro. Br J Pharmacol 1989;97:968-72.
15. Pernow J, Ahlborg G, Lundberg JM, et al. Long-lasting coronary vasoconstrictor effects and myocardial uptake of endothelin-1 in humans. Acta Physiol Scand 1997;159:147-53.
16. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-2.
17. Sahn DJ, De Maria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
18. Strauer BE, Schwartkopff B, Kelm M. Assessing the coronary circulation in hypertension. J Hypertens 1998;16:1221-33.
19. Clerico A, del Chicca MG, Zucchelli GC, et al. Critical evaluation of endothelins assay. Int J Tissue React 1994;16:79-87.
20. Schuller M, Stetter R, Skrabal S, et al. Radioimmunoassay of immunreactive C-terminal big-endothelin. Eur J Clin Chem Clin Biochem 1991;29:147-50.
21. Webb DJ. Endothelin: from molecule to man. Br J Clin Pharmacol 1997;44:9-20.
22. Cody RJ, Haas GJ, Binkley PF, et al. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9.
23. Tsutamoto T, Wada A, Maeda Y, et al. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol 1994;23:1427-33.
24. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-9.
25. Dupuis J, Stewart DJ, Cernacek P, et al. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996;94:1578-84.
26. Dupuis J, Goresky CA, Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ET-B receptors. J Appl Physiol 1996;81:1510-15.
27. Yamamoto K, Ikeda U, Mito H, et al. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 1994;89:2093-8.
28. White M, Rouleau JL, Ruddy TD, et al. Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J Am Coll Cardiol 1991;18:1631-7.
29. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 1971: 27;416-32.
30. de Marco T, Chatterjee K, Rouleau JL, et al. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J 1988;115:809-15.
31. Cannan CR, Burnett JC, Lerman A. Enhanced coronary vasoconstriction to endothelin-B receptor activation in experimental congestive heart failure. Circulation 1996;93: 646-51.
32. Vanhoutte PM. Endothelium-dependent responses in congestive heart failure. J Mol Cell Cardiol 1996;28:2233-40.
33. Ahlborg G, Lundberg JM. Nitric oxide-endothelin 1 interaction in humans. J Appl Physiol 1997;82:1593-600.
34. Ishikawa T, Yanagisawa M, Kimura S, et al. Positive inotropic actions of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 1988;255:H970-3.
35. Winegard S. Endothelial cell regulation of contractility of the heart. Ann Rev Physiol 1997;59:505-25.